Powers Principal Bill con Oehsen presented at the Healthcare Financial Management Association (HFMA) Region 9 Annual Conference on November 12th.

Bill’s presentation, “Opportunities and Risks of Hospital Participation in the 340B Drug Pricing Program during an Era of Increased Scrutiny and Enforcement,” discussed increased administrative oversight of the 340B program, as well as how to address 340B compliance risks and to maximize the program’s value. Bill also described the impact of recent Congressional scrutiny of the 340B program on participating hospitals.

HFMA Region 9 has seven chapters that serve over 4,000 member healthcare professionals in Arkansas, Louisiana, Mississippi, Oklahoma, and Texas. The annual conference, held in New Orleans, Louisiana, brings together industry experts and senior healthcare executives to discuss industry updates.

To learn more, see the HFMA Region 9 Conference agenda.

Bill has extensive experience in general health law, legislation and policy, especially in the areas of pharmaceutical pricing, food and drug law, materials management, managed care and third party reimbursement. He has more than 27 years of experience on pharmaceutical pricing and reimbursement matters, including the 340B drug discount program, the Medicaid drug rebate program, Medicare Part D, Robinson-Patman, and state Medicaid and pharmacy laws. In addition to representing safety-net providers participating in the 340B program, Bill provides guidance to pharmacies, pharmacy-related vendors and consultants, states, local governments, and other healthcare entities in their efforts to improve access to pharmaceutical care and to ensure compliance with drug pricing laws.

Leave a Reply